Global Deep Brain Stimulation (DBS) Market Growth 2024-2030

Global Deep Brain Stimulation (DBS) Market Growth 2024-2030

Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.

The global Deep Brain Stimulation (DBS) market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Deep Brain Stimulation (DBS) Industry Forecast” looks at past sales and reviews total world Deep Brain Stimulation (DBS) sales in 2023, providing a comprehensive analysis by region and market sector of projected Deep Brain Stimulation (DBS) sales for 2024 through 2030. With Deep Brain Stimulation (DBS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Deep Brain Stimulation (DBS) industry.

This Insight Report provides a comprehensive analysis of the global Deep Brain Stimulation (DBS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Deep Brain Stimulation (DBS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Deep Brain Stimulation (DBS) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Deep Brain Stimulation (DBS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Deep Brain Stimulation (DBS).

Increasing prevalence of neurological disorders is one of the critical factors driving the growth of this market globally. With more than 450 million people worldwide affected by neurological disorders, such as Alzheimer disease, brain injuries, epilepsy, Parkinson’s disease (PD), strokes, peripheral neuropathy, and paralysis, the market for DBS has a positive outlook in the coming years. For instance, PD is a progressive neurological disorder that affects the central nervous system resulting in muscle stiffness and slow movement. Although PD cannot be cured completely with medicines, DBS is preferred as it can be used to improve motor symptoms. Moreover, in cases of neurological injuries that lead to paralysis or disability, DBS can be used to restore movement, reduce tremor and dyskinesia, and improve the quality of life. Furthermore, DBS also helps in improving bladder control, restoring hand grasp, and improving walking in patients. Therefore, the increasing number of neurological disorders will bolster the growth of this market in the coming years.

This report presents a comprehensive overview, market shares, and growth opportunities of Deep Brain Stimulation (DBS) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Single-channel DBS
Dual-channel DBS

Segmentation by application
Parkinson's Disease
Essential Tremor
Dystonia
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
Abbott
Beijing Pins
SceneRay

Key Questions Addressed in this Report

What is the 10-year outlook for the global Deep Brain Stimulation (DBS) market?

What factors are driving Deep Brain Stimulation (DBS) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Deep Brain Stimulation (DBS) market opportunities vary by end market size?

How does Deep Brain Stimulation (DBS) break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.